Ernest T. Hawk

Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.

G. T. Budd, E. Hawk, G. Kelloff, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.

G. Piazza, M. Nitert, J. Church, 1999, Advances in experimental medicine and biology.

Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.

V. Steele, E. Hawk, G. Kelloff, 1996, Carcinogenesis.

Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.

E. Hawk, R. Lubet, R. Jacoby, 2004, Gastroenterology.

Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.

V. Steele, G. Kelloff, M. A. Pereira, 1999, Carcinogenesis.

Aromatase inhibitors as potential cancer chemopreventives.

V. Steele, E. Hawk, C. Boone, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.